David Gruben
5PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 30, 2025
Characterization of Second-Line Therapy After First JAK Inhibitor Use: Results From the CorEvitas Rheumatoid Arthritis Registry.Joshua F Baker, Kristi V Mizelle, Wassim Saikali
|Oct 28, 2025
Response to Tofacitinib in Patients with Psoriatic Arthritis and Probable Anxiety/Depressive Disorder: A Post Hoc Analysis of Phase 3 Trials.Laure Gossec, Agustí Sellas, David C Gruben
|Nov 01, 2024
Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study.Boulos Haraoui, Majed Khraishi, Denis Choquette
|Sep 25, 2024
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status.Alexis Ogdie, Lars E Kristensen, Enrique R Soriano
|Feb 06, 2020
Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-Making.Peter C Taylor, Neil Betteridge, T Michelle Brown
Pageof 1
Frequent Collaborators
3 joint publications
Cassandra Kinch
1 joint publications
Laure Gossec
1 joint publications
Agustí Sellas
1 joint publications
Mónica Valderrama
1 joint publications
Susana Gómez
1 joint publications
Gustavo Citera
1 joint publications
Peter C Taylor
1 joint publications
Alexis Ogdie
1 joint publications
Lars E Kristensen
1 joint publications
Enrique R Soriano
